Previous close | 5.15 |
Open | 5.17 |
Bid | 5.16 x 200 |
Ask | 5.19 x 700 |
Day's range | 5.10 - 5.21 |
52-week range | 4.71 - 12.43 |
Volume | |
Avg. volume | 2,115,445 |
Market cap | 739.408M |
Beta (5Y monthly) | 1.36 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ROCKVILLE, Md. & EDMONTON, Alberta, May 09, 2024--Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024
ROCKVILLE, Md. & EDMONTON, Alberta, May 07, 2024--Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
ROCKVILLE, Md. & EDMONTON, Alberta, May 02, 2024--AURINIA PHARMACEUTICALS REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATIONAL RESULTS